dwartana followed by Virechana in Dyslipidemia, a Clinical Study
Phase 2
- Conditions
- Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
- Registration Number
- CTRI/2020/03/023890
- Lead Sponsor
- Dr Reeny Ravina Dias
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
subjects diagnosed with dyslipidemia with any of the serum lipid levels,
S. Cholesterol - 200-500mg/dl
S. Triglycerides - 150-400mg/dl
HDL - <40mg/dl
LDL - 130-400mg/dl
Subjects fit for Snehapana, Swedana, Udwartana and Virechana
VLDL - 40-200mg/dl
Exclusion Criteria
Subjects unfit for snehapana, swedana, udwartana and virechana.
Subjects with type 1 diabetes, uncontrolled diabetes mellitus, uncontrolled hypertension, cardiovascular diseases
Dyslipidemia due to endocrine or renal pathologies
Dyslipidemia due to drugs e.g. glucocorticoids etc
Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method